Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Edwards Lifesciences Corporation

Market Cap 49.01B 42.3B 38.95B 36.55B 68.56B 4,641B 69.34B 460B 180B 2,265B 184B 180B 7,856B P/E Ratio 2026 *
30.8x
P/E Ratio 2027 * 26.4x
Enterprise Value 45.52B 39.29B 36.18B 33.95B 63.69B 4,311B 64.41B 427B 167B 2,104B 171B 167B 7,298B EV / Sales 2026 *
6.75x
EV / Sales 2027 * 5.93x
Free-Float
87.23%
Yield 2026 *
-
Yield 2027 * -
1 day+1.37%
1 week+0.37%
Current month-0.22%
1 month+6.07%
3 months+5.46%
6 months+3.85%
Current year+1.21%
1 week 83.17
Extreme 83.17
87.93
1 month 80.57
Extreme 80.57
89.48
Current year 74.66
Extreme 74.66
89.48
1 year 72.3
Extreme 72.3
89.48
3 years 58.93
Extreme 58.93
96.12
5 years 58.93
Extreme 58.93
131.73
10 years 27.04
Extreme 27.04
131.73
Manager TitleAgeSince
Chief Executive Officer 58 10/05/2023
Director of Finance/CFO 43 28/05/2026
Chief Tech/Sci/R&D Officer 51 31/08/2025
Director TitleAgeSince
Director/Board Member 65 04/07/2016
Chairman 69 06/05/2024
Director/Board Member 74 15/03/2016
Date Insider Type Main position Quantity % Market Cap.
05-28Sell

Controller/Auditor

-568 0.0001%
05-26Sell

Executive/Senior Manager

-23,145 0.0040%
05-21Sell

Executive/Senior Manager

-1,500 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
+1.37%+0.37%+14.81%-4.69% 49.01B
+1.03%+0.19%+17.62%-8.92% 174B
+1.34%-1.31%-18.67%+28.93% 146B
+0.56%-1.74%-9.75%-24.05% 127B
-0.32%-3.69%-53.12%-12.29% 69.72B
+0.95%+0.34%-23.42%-33.71% 44.74B
+0.58%-3.58%+11.54%+9.37% 36.67B
+0.63%-2.08%+4.52%+36.51% 34.91B
-0.64%+0.14%-10.37%-17.53% 29.65B
-1.05%-1.68%-22.70%-11.03% 28.13B
Average +0.30%-1.73%-8.95%-3.74% 74.03B
Weighted average by Cap. +0.42%-1.82%-7.13%-2.99%

Financials

2026 *2027 *
Net sales 6.75B 5.82B 5.36B 5.03B 9.44B 639B 9.55B 63.3B 24.72B 312B 25.32B 24.78B 1,082B 7.41B 6.4B 5.89B 5.53B 10.37B 702B 10.48B 69.52B 27.14B 342B 27.8B 27.21B 1,188B
Net income 1.62B 1.4B 1.29B 1.21B 2.27B 154B 2.3B 15.24B 5.95B 75.08B 6.09B 5.97B 260B 1.89B 1.63B 1.5B 1.41B 2.65B 179B 2.68B 17.74B 6.93B 87.41B 7.1B 6.95B 303B
Net Debt -3.48B -3.01B -2.77B -2.6B -4.87B -330B -4.93B -32.67B -12.76B -161B -13.07B -12.79B -558B -5.07B -4.38B -4.03B -3.78B -7.1B -480B -7.18B -47.59B -18.58B -234B -19.03B -18.63B -813B
Logo Edwards Lifesciences Corporation
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (74%); - hemodynamic monitoring systems (9.1%); - other (16.9%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (25%), Japan (5.8%) and other (10.8%).
Employees
16,000
Date Price Change Volume
15/06/26 86.28 $ +1.37% 2,889,154
12/06/26 85.11 $ -0.76% 4,571,613
11/06/26 85.76 $ -0.26% 5,087,226
10/06/26 85.98 $ -1.78% 4,537,874
09/06/26 87.54 $ +1.97% 3,442,466
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
29
Last Close Price
86.28USD
Average target price
96.92USD
Spread / Average Target
+12.34%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!